{
    "nct_id": "NCT03650803",
    "official_title": "Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Assessment of Response to Neo-Adjuvant Chemotherapy in Breast Cancer",
    "inclusion_criteria": "* Biopsy proven cases of breast cancer\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with onlybenign lesion\n* Patients with onlyductal carcinomain situ (DCIS)\n* Patients with recurrent/ residual breast cancer in same breast\n* Pregnant women\n* Lactating Women6.Patients with ferromagnetic or otherwise non-MRI compatible aneurysm clips.\n* The presence of an implanted medical device that is not MRI-compatible, including, but not limited to: pacemaker, defibrillator\n* Patients with contraindications for MRIdue to embedded foreign metallic objects. Bullets, shrapnel, metalwork fragments, or other metallic material adds unnecessary risk to the patient.\n* Known history of severe claustrophobia\n* Patients under the age of 18\n* For patients with known history of allergic reaction to MR contrast material or abnormal kidney function (GFR < 40 mL/ min), a contrast enhanced exam will not be performed; however, a non-contrast exam may be performed in these patients.",
    "miscellaneous_criteria": ""
}